Thrivent Financial for Lutherans Sells 8,115 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
Thrivent Financial for Lutherans reduced its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report ...
Shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the firm, Ratings ...
Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.
Let’s dig into the relative performance of Fortrea (NASDAQ:FTRE) and its peers as we unravel the now-completed Q4 drug ...
StockStory.org on MSN7d
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs PeersWrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, ...
8h
WRIC ABC 8News on MSNFree Clinic of Powhatan wraps up National Nutrition Month, highlighting healthy habits year-roundNational Nutrition Month, comes to an end, the Free Clinic of Powhatan (FCP) is promoting whole-body health and healthy ...
7d
Barchart on MSNIs West Pharmaceutical Services Stock Underperforming the S&P 500?Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery ...
Pharmaceutical company sponsorship of diagnostic testing remains an area with a gaping divide between the views of regulators and industry, ...
West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is upgraded to a Buy.
Two UIC professors list their questions for the man set to lead "the crown jewel” of American biomedical science.
Saudi Arabia’s market presents significant growth opportunities across multiple industries, particularly in the healthcare, pharmaceutical, and medical device sectors. The country’s economic ...
The global medical thawing system market was valued at $165.82 million in 2019 and is expected to reach $279.17 million by 2027 with a CAGR of 11.6% during the forecast period. Increase in incidences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results